// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

PROGNOSTIC PLAQUE BIOMARKERS FOR THE RISK STRATIFICATION IN PERIPHERAL VASCULAR DISEASE

Tobias Koppara - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

COMPARISON OF ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY FOR THE EXTENDED TREATMENT OF VENOUS THROMBOEMBOLISM: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Ander Cohen - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

VALIDATION OF THE APIXABAN COST-EFFECTIVENESS MODEL IN PATIENTS WITH VENOUS THROMBOEMBOLISM

Tereza Lanitis - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

apixaban

RANDOMIZED COMPARISON OF VASCULAR HEALING RESPONSE BETWEEN SELF-EXPANDING NITINOL STENT AND SELF-EXPANDING PACLITAXEL-ELUTING STENT IN THE SUPERFICIAL FEMORAL ARTERY: AN OPTICAL FREQUENCY DOMAIN IMAGING STUDY

Kojiro Miki - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Paclitaxel

SEX DIFFERENCES IN UTILIZATION AND OUTCOMES OF CATHETER DIRECTED THROMBOLYSIS IN PATIENTS WITH PROXIMAL LOWER EXTREMITY DEEP VENOUS THROMBOSIS

Vladimir Lakhter - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methadone hydrochloride

PARTICULATE MATTER-INDUCED PROCOAGULANT MICROPARTICLE GENERATION BY HUMAN MONONUCLEAR CELLS: A POSSIBLE NOVEL LINK BETWEEN AIRBORNE POLLUTANTS AND CARDIOVASCULAR DISEASES

Tommaso Neri - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Phosphatidylserine

TICAGRELOR INHIBITS CHANGES IN FIBRIN CLOT STRUCTURE INDUCED BY BACTERIAL ENDOTOXEMIA

Mark R. Thomas - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

THERAPEUTIC WINDOW FOR P2Y12-RECEPTOR INHIBITION: A COLLABORATIVE ANALYSIS OF THE RELATION BETWEEN PLATELET REACTIVITY, STENT THROMBOSIS AND BLEEDING

Daniel Aradi - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

TEMPORAL TRENDS IN CARE AND OUTCOMES OF PATIENTS WITH CARDIOGENIC SHOCK UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A REPORT FROM THE NCDR

Siddharth A. Wayangankar - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Bivalirudin

TRENDS AND PREDICTORS OF LENGTH OF HOSPITALIZATION IN PATIENTS ADMITTED WITH UNSTABLE ANGINA IN UNITED STATES

Yasir Akram - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

TWO-YEAR SAFETY AND EFFICACY OF DURABLE POLYMER SECOND-GENERATION DRUG-ELUTING STENT VERSUS BIODEGRADABLE POLYMER DRUG-ELUTING STENT IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: DATA FROM KOREA ACUTE MYOCARDIAL INFARCTION REGISTRY (KAMIR)

In-Cheol Kim - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

A RANDOMIZED COMPARISON OF SECOND-GENERATION ZOTAROLIMUS-ELUTING RESOLUTE STENTS VERSUS EVEROLIMUS-ELUTING XIENCE V STENTS IN REAL-WORLD PATIENTS: 4-YEAR LONG-TERM CLINICAL OUTCOMES OF LISA-ERX TRIAL

Yisik Kim - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

TEMPORAL COURSE OF NEOINTIMAL HYPERPLASIA FOLLOWING DRUG ELUTING STENT IMPLANTATION AS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY

Haris Riaz - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

NORTON SCALE FOR PREDICTING PROGNOSIS IN ELDERLY PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST ELEVATION MYOCARDIAL INFARCTION

Eran Leshem-Rubinow - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

REVASCULARIZATION STRATEGIES FOR PATIENTS WITH MULTIPLE VESSEL DISEASE AND UNPROTECTED LEFT MAIN WITH A COBALT-CHROMIUM RAPAMYCIN ELUTING STENT: TWO YEARS RESULTS FROM ERACI IV REGISTRY

Alfredo Matias Rodriguez-Granillo - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Rapacan

STAGED APPROACH TO CORONARY HYBRID CORONARY REVASCULARIZATION IN 515 CONSECUTIVE PATIENTS

Francis P. Sutter - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

CLINICAL OUTCOMES AFTER SINGLE CROSS-OVER BIORESORBABLE SCAFFOLD IMPLANTATION WITH OR WITHOUT SIDE BRANCH STRUTS DILATATION

Akihito Tanaka - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

EIGHT-YEAR CLINICAL OUTCOME OF SIROLIMUS-ELUTING STENT IMPLANTATION FOR CHRONIC TOTAL OCCLUSION LESIONS COMPARED WITH NON-CHRONIC TOTAL OCCLUSION LESIONS

Mizuki Miura - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

TROPOELASTIN-BOUND PLASMA-ACTIVATED STENTS STRIKINGLY REDUCE THROMBOGENICITY WHILE SIMULTANEOUSLY INHIBITING NEOINTIMAL HYPERPLASIA

Steven Wise - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Rapacan

ETIOLOGY, TIMING AND IMPACT OF DUAL ANTIPLATELET THERAPY DISCONTINUATION AFTER DRUG-ELUTING STENT IMPLANTATION: INSIGHTS FROM THE ADAPT-DES STUDY

Daniel Musikantowa - American College of Cardiology (ACC) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Copyright © 2026. QuantiNova All rights reserved